Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: immunohistochemical findings
Authors:
- 1 January 1993
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 423 (1) , 19-27
Abstract
Specimens of 27 histologically definite mesotheliomas and 34 proven adenocarcinomas were examined with a panel of 14 antibodies: pan-epithelial antibody Lu-5, anti-keratin-18, anti-keratin-7, Ber-EP4, anti-Leu-M1, HEA-125, anti-carcino-embryonic antigen (CEA), anti-blood group-related antigens (anti-BGR A, B, H), B 72.3, anti-placental alkaline phosphatase (PLAP), anti-vimentin and BMA-120 used to determine their value in the differentiation between pleural mesothelioma and lung adenocarcinoma. Lu-5, anti-cytokeratin-7 and -18, B 72.3 and PLAP reacted in a high percentage of cases with both mesothelioma and adenocarcinoma. Anti-CEA and anti-Leu-Ml did not react with any of the 27 mesotheliomas tested but showed a reaction in 75% (anti-CEA) and 66% (anti-Leu-M1) of the lung adenocarcinomas. Seventeen percent of the adenocarcinomas and 96% of the mesotheliomas showed a positive reaction with anti-vimentin. Ber-EP4 was demonstrated in all lung adenocarcinomas, but only in 2 mesotheliomas in a focal manner (7%). HEA-125 and anti-BGR A, B, H reacted with 83% (HEA-125) and 75% (anti-BGR A, B, H) of the lung adenocarcinomas. The statistical parameters, sensitivity and efficiency were estimated and a normogram for judging the diagnostic power of a single antibody for the differential diagnosis of mesothelioma versus adenocarcinoma was developed. According to this, Ber-EP4, HEA-125, anti-BGR A, B, H and anti-CEA were, in descending order, the most powerful discriminatory antibodies.Keywords
This publication has 38 references indexed in Scilit:
- Immunoreactivity for BER-EP4 in Adenocarcinomas, Adenomatoid Tumors, and Malignant MesotheliomasAmerican Journal of Surgical Pathology, 1992
- Monoclonal Antibody K1 Reacts With Epithelial Mesothelioma but not With Lung AdenocarcinomaAmerican Journal of Surgical Pathology, 1992
- A Novel Biotinylated Probe Specific for HyaluronateAmerican Journal of Surgical Pathology, 1992
- Ber-EP4 Antibody as a Discriminant in the Differential Diagnosis of Malignant Mesothelioma Versus AdenocarcinomaAmerican Journal of Surgical Pathology, 1991
- The differential diagnosis of epithelial‐type mesothelioma from adenocarcinoma and reactive mesothelial proliferationThe Journal of Pathology, 1991
- Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: An ultrastructural and cytochemical comparisonThe Journal of Pathology, 1987
- Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.Journal of Clinical Pathology, 1987
- Immunohistochemical and immunochemical characterization of a new endothelial cell-specific antigen.Journal of Histochemistry & Cytochemistry, 1986
- Immunohistological study of malignant diffuse mesotheliomas of the pleuraHistopathology, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981